https://www.marketscreener.com/quote/stock/DAIICHI-SANKYO-CO-LTD-6498062/news/Daiichi-Sankyo-EMA-Validates-and-Grants-Accelerated-Assessment-for-Trastuzumab-Deruxtecan-for-the-30906374/?utm_source=telegram&utm_medium=social&utm_campaign=share